25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

CTCBIO Inc
Buy, Hold or Sell?

Let's analyze Ctcbio together

I guess you are interested in CTCBIO Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of CTCBIO Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about CTCBIO Inc

I send you an email if I find something interesting about CTCBIO Inc.

1. Quick Overview

1.1. Quick analysis of Ctcbio (30 sec.)










1.2. What can you expect buying and holding a share of Ctcbio? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
₩3,051.14
Expected worth in 1 year
₩2,255.28
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
₩-795.86
Return On Investment
-12.1%

For what price can you sell your share?

Current Price per Share
₩6,580.00
Expected price per share
₩6,000 - ₩8,230
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Ctcbio (5 min.)




Live pricePrice per Share (EOD)
₩6,580.00

2.2. Growth of Ctcbio (5 min.)




Is Ctcbio growing?

Current yearPrevious yearGrowGrow %
How rich?$51m$66.8m-$12m-22.0%

How much money is Ctcbio making?

Current yearPrevious yearGrowGrow %
Making money-$2.8m-$788.4k-$2m-72.1%
Net Profit Margin-11.7%-3.2%--

How much money comes from the company's main activities?

2.3. Financial Health of Ctcbio (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Ctcbio?

Welcome investor! Ctcbio's management wants to use your money to grow the business. In return you get a share of Ctcbio.

First you should know what it really means to hold a share of Ctcbio. And how you can make/lose money.

Speculation

The Price per Share of Ctcbio is ₩6,580. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ctcbio.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ctcbio, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩3,051.14. Based on the TTM, the Book Value Change Per Share is ₩-198.97 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-81.54 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ctcbio.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.070.0%-0.120.0%-0.030.0%-0.070.0%-0.050.0%
Usd Book Value Change Per Share-0.070.0%-0.140.0%-0.060.0%-0.010.0%-0.010.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.070.0%-0.140.0%-0.060.0%-0.010.0%-0.010.0%
Usd Price Per Share5.39-6.75-5.73-5.88-7.59-
Price to Earnings Ratio-20.41--58.98--174.02--51.29-178.50-
Price-to-Total Gains Ratio-82.22--255.02--746.85--206.22--192.33-
Price to Book Ratio2.52-2.94-2.06-2.41-2.99-
Price-to-Total Gains Ratio-82.22--255.02--746.85--206.22--192.33-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.606
Number of shares217
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.14-0.01
Usd Total Gains Per Share-0.14-0.01
Gains per Quarter (217 shares)-30.22-2.28
Gains per Year (217 shares)-120.89-9.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-121-1310-9-19
20-242-2520-18-28
30-363-3730-27-37
40-484-4940-37-46
50-604-6150-46-55
60-725-7360-55-64
70-846-8570-64-73
80-967-9780-73-82
90-1088-10990-82-91
100-1209-12200-91-100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%11.024.05.027.5%13.024.09.028.3%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%8.012.00.040.0%15.025.00.037.5%18.028.00.039.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.046.00.0%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%8.012.00.040.0%15.025.00.037.5%18.028.00.039.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of CTCBIO Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---93.652-198.965+112%-81.542-13%-15.034-84%-15.956-83%
Book Value Per Share--3051.1453273.210-7%3993.802-24%3510.885-13%3616.366-16%
Current Ratio--1.1101.137-2%1.337-17%1.219-9%0.851+30%
Debt To Asset Ratio--0.5470.532+3%0.485+13%0.530+3%0.526+4%
Debt To Equity Ratio--1.2091.141+6%0.941+28%1.148+5%1.139+6%
Dividend Per Share----0%-0%-0%-0%
Enterprise Value--95887357000.000148597622835.000-35%130641291677.500-27%121806844742.000-21%170240420776.000-44%
Eps---94.307-168.908+79%-47.112-50%-93.644-1%-75.833-20%
Ev To Ebitda Ratio--infinfnan%infnan%infnan%infnan%
Ev To Sales Ratio--0.6891.119-38%0.902-24%0.861-20%1.315-48%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%0.875+14%
Market Cap157319904000.000-17%184097760000.000230660148000.000-20%195693528000.000-6%200989327200.000-8%259093688400.000-29%
Net Profit Margin---0.065-0.117+81%-0.032-51%-0.071+10%-0.056-14%
Operating Margin----0%-0.0030%-0.0110%-0.0200%
Operating Ratio--1.2451.613-23%1.360-8%1.105+13%1.153+8%
Pb Ratio2.157-17%2.5242.938-14%2.061+22%2.412+5%2.988-16%
Pe Ratio-17.443+15%-20.412-58.978+189%-174.016+753%-51.290+151%178.495-111%
Price Per Share6580.000-17%7700.0009647.500-20%8185.000-6%8406.500-8%10836.750-29%
Price To Free Cash Flow Ratio----52.8600%31.869-100%30.473-100%84.908-100%
Price To Total Gains Ratio-70.260+15%-82.219-255.024+210%-746.854+808%-206.218+151%-192.331+134%
Quick Ratio---0.336-100%0.796-100%0.668-100%0.592-100%
Return On Assets---0.014-0.024+73%-0.006-57%-0.013-9%-0.010-29%
Return On Equity---0.031-0.052+70%-0.012-62%-0.030-3%-0.024-22%
Total Gains Per Share---93.652-198.965+112%-81.542-13%-15.034-84%-15.956-83%
Usd Book Value--51064446.30054780964.884-7%66840916.711-24%58758737.798-13%60524076.789-16%
Usd Book Value Change Per Share---0.066-0.139+112%-0.057-13%-0.011-84%-0.011-83%
Usd Book Value Per Share--2.1362.291-7%2.796-24%2.458-13%2.531-16%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Enterprise Value--67121149.900104018335.985-35%91448904.174-27%85264791.319-21%119168294.543-44%
Usd Eps---0.066-0.118+79%-0.033-50%-0.066-1%-0.053-20%
Usd Free Cash Flow----823225.7690%1800470.796-100%787577.372-100%-841500.1060%
Usd Market Cap110123932.800-17%128868432.000161462103.600-20%136985469.600-6%140692529.040-8%181365581.880-29%
Usd Price Per Share4.606-17%5.3906.753-20%5.730-6%5.885-8%7.586-29%
Usd Profit---1578332.000-2826870.970+79%-788474.983-50%-1567238.382-1%-1269155.917-20%
Usd Revenue--24372180.00023510571.109+4%25473397.280-4%24948911.965-2%23619457.418+3%
Usd Total Gains Per Share---0.066-0.139+112%-0.057-13%-0.011-84%-0.011-83%
 EOD+3 -4MRQTTM+15 -14YOY+4 -275Y+4 -2710Y+8 -23

3.3 Fundamental Score

Let's check the fundamental score of CTCBIO Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-17.443
Price to Book Ratio (EOD)Between0-12.157
Net Profit Margin (MRQ)Greater than0-0.065
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than11.110
Debt to Asset Ratio (MRQ)Less than10.547
Debt to Equity Ratio (MRQ)Less than11.209
Return on Equity (MRQ)Greater than0.15-0.031
Return on Assets (MRQ)Greater than0.05-0.014
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of CTCBIO Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.363
Ma 20Greater thanMa 506,772.500
Ma 50Greater thanMa 1007,334.800
Ma 100Greater thanMa 2007,312.300
OpenGreater thanClose6,610.000
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About CTCBIO Inc

CTCBIO Inc. provides various pharmaceutical products in South Korea and internationally. The company offers animal and human pharmaceuticals; feed additives and ingredients; and functional food products. It also provides cardiovascular, gastrointestinal, osteoporosis, antibiotic, smoking cessation, antifungal and antiviral, antiepileptic, allergic rhinitis, dermatology and genito-urinory, allergic rhinitis and antihistamine, neuropsychiarty, intestinal disorders, X-ray, diabetes, anti-inflammatory and arthritis, and harmones, as well as CTC covid-19 IgM/IgG combo test, a quick antibody test kit on covid-19. In addition, the company offers coating base/plasticizer/pore former, diluting agents, bonding agents, disintegrating agents, lubricants, solubilizer/biopharma, topicals, APIs, and food/health functional foods, as well as animal drugs, physiological activators, functional enhancers, and disinfectants. CTCBIO Inc. was founded in 1993 and is headquartered in Hwaseong-si, South Korea.

Fundamental data was last updated by Penke on 2024-12-09 19:17:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Ctcbio earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • A Net Profit Margin of -6.5% means that ₩-0.06 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of CTCBIO Inc:

  • The MRQ is -6.5%. The company is making a loss. -1
  • The TTM is -11.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-6.5%TTM-11.7%+5.3%
TTM-11.7%YOY-3.2%-8.6%
TTM-11.7%5Y-7.1%-4.6%
5Y-7.1%10Y-5.6%-1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-6.5%-109.0%+102.5%
TTM-11.7%-220.8%+209.1%
YOY-3.2%-207.5%+204.3%
5Y-7.1%-350.0%+342.9%
10Y-5.6%-473.2%+467.6%
4.3.1.2. Return on Assets

Shows how efficient Ctcbio is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • -1.4% Return on Assets means that Ctcbio generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of CTCBIO Inc:

  • The MRQ is -1.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.4%TTM-2.4%+1.0%
TTM-2.4%YOY-0.6%-1.8%
TTM-2.4%5Y-1.3%-1.1%
5Y-1.3%10Y-1.0%-0.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.4%-11.6%+10.2%
TTM-2.4%-11.9%+9.5%
YOY-0.6%-11.2%+10.6%
5Y-1.3%-12.6%+11.3%
10Y-1.0%-14.2%+13.2%
4.3.1.3. Return on Equity

Shows how efficient Ctcbio is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • -3.1% Return on Equity means Ctcbio generated ₩-0.03 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of CTCBIO Inc:

  • The MRQ is -3.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -5.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.1%TTM-5.2%+2.2%
TTM-5.2%YOY-1.2%-4.1%
TTM-5.2%5Y-3.0%-2.3%
5Y-3.0%10Y-2.4%-0.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.1%-14.3%+11.2%
TTM-5.2%-15.9%+10.7%
YOY-1.2%-14.7%+13.5%
5Y-3.0%-18.5%+15.5%
10Y-2.4%-19.2%+16.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of CTCBIO Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Ctcbio is operating .

  • Measures how much profit Ctcbio makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of CTCBIO Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.3%+0.3%
TTM-5Y-1.1%+1.1%
5Y-1.1%10Y-2.0%+0.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--208.0%+208.0%
TTM--316.8%+316.8%
YOY-0.3%-216.9%+216.6%
5Y-1.1%-379.8%+378.7%
10Y-2.0%-480.9%+478.9%
4.3.2.2. Operating Ratio

Measures how efficient Ctcbio is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.24 means that the operating costs are ₩1.24 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of CTCBIO Inc:

  • The MRQ is 1.245. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.613. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.245TTM1.613-0.368
TTM1.613YOY1.360+0.253
TTM1.6135Y1.105+0.508
5Y1.10510Y1.153-0.048
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2452.284-1.039
TTM1.6133.244-1.631
YOY1.3603.262-1.902
5Y1.1054.764-3.659
10Y1.1536.437-5.284
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of CTCBIO Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Ctcbio is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.11 means the company has ₩1.11 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of CTCBIO Inc:

  • The MRQ is 1.110. The company is just able to pay all its short-term debts.
  • The TTM is 1.137. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.110TTM1.137-0.027
TTM1.137YOY1.337-0.200
TTM1.1375Y1.219-0.082
5Y1.21910Y0.851+0.368
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1103.569-2.459
TTM1.1373.865-2.728
YOY1.3374.644-3.307
5Y1.2195.968-4.749
10Y0.8516.209-5.358
4.4.3.2. Quick Ratio

Measures if Ctcbio is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of CTCBIO Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.336-0.336
TTM0.336YOY0.796-0.460
TTM0.3365Y0.668-0.332
5Y0.66810Y0.592+0.076
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.086-3.086
TTM0.3363.384-3.048
YOY0.7964.304-3.508
5Y0.6685.954-5.286
10Y0.5926.436-5.844
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of CTCBIO Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Ctcbio assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ctcbio to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.55 means that Ctcbio assets are financed with 54.7% credit (debt) and the remaining percentage (100% - 54.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of CTCBIO Inc:

  • The MRQ is 0.547. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.532. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.547TTM0.532+0.015
TTM0.532YOY0.485+0.047
TTM0.5325Y0.530+0.003
5Y0.53010Y0.526+0.003
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5470.346+0.201
TTM0.5320.346+0.186
YOY0.4850.311+0.174
5Y0.5300.365+0.165
10Y0.5260.383+0.143
4.5.4.2. Debt to Equity Ratio

Measures if Ctcbio is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ctcbio to the Biotechnology industry mean.
  • A Debt to Equity ratio of 120.9% means that company has ₩1.21 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of CTCBIO Inc:

  • The MRQ is 1.209. The company is able to pay all its debts with equity. +1
  • The TTM is 1.141. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.209TTM1.141+0.068
TTM1.141YOY0.941+0.200
TTM1.1415Y1.148-0.007
5Y1.14810Y1.139+0.009
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2090.393+0.816
TTM1.1410.432+0.709
YOY0.9410.387+0.554
5Y1.1480.453+0.695
10Y1.1390.498+0.641
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Ctcbio generates.

  • Above 15 is considered overpriced but always compare Ctcbio to the Biotechnology industry mean.
  • A PE ratio of -20.41 means the investor is paying ₩-20.41 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of CTCBIO Inc:

  • The EOD is -17.443. Based on the earnings, the company is expensive. -2
  • The MRQ is -20.412. Based on the earnings, the company is expensive. -2
  • The TTM is -58.978. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-17.443MRQ-20.412+2.969
MRQ-20.412TTM-58.978+38.566
TTM-58.978YOY-174.016+115.037
TTM-58.9785Y-51.290-7.688
5Y-51.29010Y178.495-229.786
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-17.443-2.088-15.355
MRQ-20.412-2.565-17.847
TTM-58.978-3.166-55.812
YOY-174.016-3.244-170.772
5Y-51.290-6.006-45.284
10Y178.495-6.718+185.213
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of CTCBIO Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-52.860+52.860
TTM-52.860YOY31.869-84.729
TTM-52.8605Y30.473-83.333
5Y30.47310Y84.908-54.435
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.295+3.295
TTM-52.860-3.674-49.186
YOY31.869-4.477+36.346
5Y30.473-8.054+38.527
10Y84.908-9.225+94.133
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Ctcbio is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.52 means the investor is paying ₩2.52 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of CTCBIO Inc:

  • The EOD is 2.157. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.524. Based on the equity, the company is underpriced. +1
  • The TTM is 2.938. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.157MRQ2.524-0.367
MRQ2.524TTM2.938-0.414
TTM2.938YOY2.061+0.877
TTM2.9385Y2.412+0.526
5Y2.41210Y2.988-0.576
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.1571.866+0.291
MRQ2.5242.055+0.469
TTM2.9382.392+0.546
YOY2.0612.453-0.392
5Y2.4123.716-1.304
10Y2.9884.373-1.385
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets161,159,612
Total Liabilities88,210,403
Total Stockholder Equity72,949,209
 As reported
Total Liabilities 88,210,403
Total Stockholder Equity+ 72,949,209
Total Assets = 161,159,612

Assets

Total Assets161,159,612
Total Current Assets79,955,644
Long-term Assets81,203,968
Total Current Assets
Total Current Assets  (as reported)79,955,644
Total Current Assets  (calculated)0
+/- 79,955,644
Long-term Assets
Long-term Assets  (as reported)81,203,968
Long-term Assets  (calculated)0
+/- 81,203,968

Liabilities & Shareholders' Equity

Total Current Liabilities72,018,441
Long-term Liabilities16,191,961
Total Stockholder Equity72,949,209
Total Current Liabilities
Total Current Liabilities  (as reported)72,018,441
Total Current Liabilities  (calculated)0
+/- 72,018,441
Long-term Liabilities
Long-term Liabilities  (as reported)16,191,961
Long-term Liabilities  (calculated)0
+/- 16,191,961
Total Stockholder Equity
Total Stockholder Equity (as reported)72,949,209
Total Stockholder Equity (calculated)0
+/- 72,949,209
Other
Common Stock Shares Outstanding 23,909
Net Invested Capital 72,949,209
Net Working Capital 7,937,203



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-31
> Total Assets 
126,311,495
152,340,767
151,623,112
150,475,744
160,591,533
147,476,891
158,997,419
162,122,551
164,162,984
184,039,395
185,019,592
193,613,516
202,883,595
195,506,806
192,984,576
188,675,020
181,395,130
190,667,337
187,918,852
196,899,089
195,925,436
194,436,779
193,285,215
191,687,184
196,638,013
193,320,161
181,031,879
186,497,921
180,767,339
183,388,167
188,789,861
177,172,050
183,005,261
175,679,607
171,055,615
168,226,116
180,937,853
183,484,351
187,671,501
187,899,527
183,329,272
182,222,480
178,443,256
165,861,819
162,580,973
161,159,612
161,159,612162,580,973165,861,819178,443,256182,222,480183,329,272187,899,527187,671,501183,484,351180,937,853168,226,116171,055,615175,679,607183,005,261177,172,050188,789,861183,388,167180,767,339186,497,921181,031,879193,320,161196,638,013191,687,184193,285,215194,436,779195,925,436196,899,089187,918,852190,667,337181,395,130188,675,020192,984,576195,506,806202,883,595193,613,516185,019,592184,039,395164,162,984162,122,551158,997,419147,476,891160,591,533150,475,744151,623,112152,340,767126,311,495
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
72,638,294
74,397,711
71,985,823
71,601,063
72,697,196
72,380,064
78,602,566
84,524,084
81,959,589
73,817,862
82,587,409
82,532,203
82,603,246
87,149,199
74,992,289
84,826,573
76,633,301
72,060,391
70,693,859
81,749,343
83,915,564
88,945,890
89,836,284
85,499,385
88,340,243
85,105,878
84,118,519
80,506,153
79,955,644
79,955,64480,506,15384,118,51985,105,87888,340,24385,499,38589,836,28488,945,89083,915,56481,749,34370,693,85972,060,39176,633,30184,826,57374,992,28987,149,19982,603,24682,532,20382,587,40973,817,86281,959,58984,524,08478,602,56672,380,06472,697,19671,601,06371,985,82374,397,71172,638,29400000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,544,209
3,023,099
6,531,866
1,918,158
1,768,561
1,559,296
4,625,801
5,894,775
5,547,425
2,223,163
15,229,577
16,207,625
12,870,052
17,076,792
12,136,757
17,892,167
13,656,699
10,294,304
41,597
41,316
39,331
38,743
196
3,091
1,879
5,081
24,629,017
21,293,614
0
021,293,61424,629,0175,0811,8793,09119638,74339,33141,31641,59710,294,30413,656,69917,892,16712,136,75717,076,79212,870,05216,207,62515,229,5772,223,1635,547,4255,894,7754,625,8011,559,2961,768,5611,918,1586,531,8663,023,0995,544,20900000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,706,825
5,369,070
2,628,940
1,891,000
1,263,000
1,566,000
9,870,000
13,692,000
8,260,000
6,780,000
0
0
0
2,820,000
2,502,000
4,445,000
2,228,000
1,201,000
280,000
130,000
212,000
305,000
398,000
110,000
0
0
50,000
50,000
0
050,00050,00000110,000398,000305,000212,000130,000280,0001,201,0002,228,0004,445,0002,502,0002,820,0000006,780,0008,260,00013,692,0009,870,0001,566,0001,263,0001,891,0002,628,9405,369,0702,706,82500000000000000000
       Net Receivables 
35,181,362
37,054,577
40,904,284
38,631,699
37,117,740
34,856,868
37,090,496
34,375,219
35,648,383
34,605,564
33,612,233
35,816,325
31,312,717
31,236,200
33,820,483
34,711,199
33,134,436
33,870,319
31,814,972
29,484,559
33,753,141
31,998,370
31,931,728
31,783,910
29,840,211
28,122,298
28,623,902
36,029,335
33,038,627
32,703,105
34,090,257
29,056,598
31,609,726
27,648,846
30,150,526
30,564,097
38,648,831
31,083,895
30,440,748
27,804,539
27,015,597
24,837,906
22,152,605
24,158,369
24,280,040
0
024,280,04024,158,36922,152,60524,837,90627,015,59727,804,53930,440,74831,083,89538,648,83130,564,09730,150,52627,648,84631,609,72629,056,59834,090,25732,703,10533,038,62736,029,33528,623,90228,122,29829,840,21131,783,91031,931,72831,998,37033,753,14129,484,55931,814,97233,870,31933,134,43634,711,19933,820,48331,236,20031,312,71735,816,32533,612,23334,605,56435,648,38334,375,21937,090,49634,856,86837,117,74038,631,69940,904,28437,054,57735,181,362
       Other Current Assets 
2,253,452
2,564,639
2,085,586
1,598,405
2,470,018
2,348,985
2,340,218
2,621,443
2,706,963
4,730,311
3,862,521
3,548,903
3,768,334
5,785,332
5,130,188
2,741,784
2,719,770
2,513,783
3,821,822
1,052,601
1,421,085
1,792,869
1,568,933
1,375,561
1,442,027
1,614,144
204,660
1,149,819
1,285,854
1,377,703
1,192,434
855,158
2,012,019
1,142,046
1,070,658
135,455
135,455
1,019,764
1,850,635
1,102,078
97,547
83,943
66,403
69,671
64,591
0
064,59169,67166,40383,94397,5471,102,0781,850,6351,019,764135,455135,4551,070,6581,142,0462,012,019855,1581,192,4341,377,7031,285,8541,149,819204,6601,614,1441,442,0271,375,5611,568,9331,792,8691,421,0851,052,6013,821,8222,513,7832,719,7702,741,7845,130,1885,785,3323,768,3343,548,9033,862,5214,730,3112,706,9632,621,4432,340,2182,348,9852,470,0181,598,4052,085,5862,564,6392,253,452
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
98,063,243
97,829,887
93,882,237
93,337,378
81,743,300
82,074,820
81,203,968
81,203,96882,074,82081,743,30093,337,37893,882,23797,829,88798,063,243000000000000000000000000000000000000000
       Property Plant Equipment 
29,718,757
29,176,669
30,591,784
33,546,687
35,683,533
42,380,824
57,689,765
66,289,976
67,965,749
70,255,516
79,803,594
86,787,547
90,585,320
91,322,642
91,250,055
92,013,255
91,389,748
91,309,534
90,573,717
91,444,735
90,614,209
89,774,878
89,288,410
88,438,382
89,512,261
88,679,182
87,971,128
82,308,841
81,214,849
81,327,064
81,291,595
80,304,925
79,578,142
79,650,060
79,434,840
78,964,666
81,021,313
81,413,903
80,564,028
74,991,681
73,978,861
72,201,150
71,362,978
62,081,112
61,864,118
0
061,864,11862,081,11271,362,97872,201,15073,978,86174,991,68180,564,02881,413,90381,021,31378,964,66679,434,84079,650,06079,578,14280,304,92581,291,59581,327,06481,214,84982,308,84187,971,12888,679,18289,512,26188,438,38289,288,41089,774,87890,614,20991,444,73590,573,71791,309,53491,389,74892,013,25591,250,05591,322,64290,585,32086,787,54779,803,59470,255,51667,965,74966,289,97657,689,76542,380,82435,683,53333,546,68730,591,78429,176,66929,718,757
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,962,519
14,598,919
19,514,461
19,799,591
17,672,538
16,968,102
16,597,398
12,210,901
12,740,748
10,002,184
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000010,002,18412,740,74812,210,90116,597,39816,968,10217,672,53819,799,59119,514,46114,598,91917,962,51900000000000000000
       Intangible Assets 
2,700,285
1,455,635
3,003,334
1,833,861
2,657,573
1,794,029
1,790,554
2,404,868
2,383,150
2,362,950
2,347,846
2,844,967
2,863,734
2,830,478
2,855,951
2,838,982
2,796,153
3,250,288
3,274,165
3,322,974
3,311,503
2,826,406
2,865,714
2,804,362
2,779,176
2,755,949
7,934,942
7,602,639
8,155,158
10,342,490
11,286,049
12,159,580
12,073,842
12,842,276
13,236,186
11,895,269
12,060,652
12,119,555
12,121,023
11,793,595
11,778,548
11,891,006
11,938,729
11,264,136
11,182,334
0
011,182,33411,264,13611,938,72911,891,00611,778,54811,793,59512,121,02312,119,55512,060,65211,895,26913,236,18612,842,27612,073,84212,159,58011,286,04910,342,4908,155,1587,602,6397,934,9422,755,9492,779,1762,804,3622,865,7142,826,4063,311,5033,322,9743,274,1653,250,2882,796,1532,838,9822,855,9512,830,4782,863,7342,844,9672,347,8462,362,9502,383,1502,404,8681,790,5541,794,0292,657,5731,833,8613,003,3341,455,6352,700,285
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,644,121
0
-1
0
0
0
000-106,644,1210000000000000000000000000000000000000000
> Total Liabilities 
60,772,654
57,165,493
58,940,543
58,249,215
67,792,389
59,267,675
70,903,609
76,632,353
73,701,459
83,316,023
89,254,867
94,445,814
97,940,130
96,634,159
96,317,066
97,751,778
93,530,396
99,092,217
104,067,239
122,821,446
120,216,452
122,612,560
102,540,160
104,721,613
110,799,676
113,182,039
106,005,081
111,759,282
107,021,040
108,794,587
112,891,228
100,856,368
101,048,757
91,416,183
85,764,299
83,213,403
83,718,142
83,708,751
87,956,836
91,936,489
89,036,165
90,245,195
88,991,013
90,417,497
87,392,661
88,210,403
88,210,40387,392,66190,417,49788,991,01390,245,19589,036,16591,936,48987,956,83683,708,75183,718,14283,213,40385,764,29991,416,183101,048,757100,856,368112,891,228108,794,587107,021,040111,759,282106,005,081113,182,039110,799,676104,721,613102,540,160122,612,560120,216,452122,821,446104,067,23999,092,21793,530,39697,751,77896,317,06696,634,15997,940,13094,445,81489,254,86783,316,02373,701,45976,632,35370,903,60959,267,67567,792,38958,249,21558,940,54357,165,49360,772,654
   > Total Current Liabilities 
48,471,397
44,972,058
47,252,966
47,406,835
57,691,748
49,832,774
54,183,788
59,047,204
58,513,138
61,507,249
66,371,884
69,459,490
72,802,711
73,694,881
75,029,858
78,740,234
77,428,742
81,211,473
65,599,307
70,522,438
67,327,775
73,950,088
73,063,802
65,719,150
68,753,540
70,540,438
62,918,037
87,337,441
83,449,553
81,969,275
76,531,110
62,498,302
72,895,935
62,796,394
55,819,907
60,156,332
56,281,030
48,650,832
57,261,590
63,862,379
71,785,386
73,749,262
72,591,364
74,315,911
70,946,058
72,018,441
72,018,44170,946,05874,315,91172,591,36473,749,26271,785,38663,862,37957,261,59048,650,83256,281,03060,156,33255,819,90762,796,39472,895,93562,498,30276,531,11081,969,27583,449,55387,337,44162,918,03770,540,43868,753,54065,719,15073,063,80273,950,08867,327,77570,522,43865,599,30781,211,47377,428,74278,740,23475,029,85873,694,88172,802,71169,459,49066,371,88461,507,24958,513,13859,047,20454,183,78849,832,77457,691,74847,406,83547,252,96644,972,05848,471,397
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,153,581
3,794,283
3,482,863
2,842,863
2,759,530
2,822,030
3,038,330
2,888,320
2,890,100
46,067,561
37,053,505
35,866,076
35,152,064
33,594,555
32,053,498
30,566,894
30,318,950
27,858,647
25,885,663
24,784,562
26,643,496
30,152,227
30,933,763
28,355,730
29,172,237
29,922,975
0
0
0
00029,922,97529,172,23728,355,73030,933,76330,152,22726,643,49624,784,56225,885,66327,858,64730,318,95030,566,89432,053,49833,594,55535,152,06435,866,07637,053,50546,067,5612,890,1002,888,3203,038,3302,822,0302,759,5302,842,8633,482,8633,794,28377,153,58100000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
77,153,581
3,794,283
3,482,863
2,842,863
2,759,530
2,822,030
3,038,330
2,888,320
2,890,100
2,275,800
0
0
0
0
0
0
0
0
0
0
0
0
32,105,143
29,527,110
30,343,617
31,094,356
30,512,023
31,028,784
0
031,028,78430,512,02331,094,35630,343,61729,527,11032,105,1430000000000002,275,8002,890,1002,888,3203,038,3302,822,0302,759,5302,842,8633,482,8633,794,28377,153,58100000000000000000
       Accounts payable 
6,281,491
6,767,861
7,902,794
7,370,575
9,044,074
6,635,529
5,649,562
6,315,152
6,293,271
5,943,662
5,747,398
6,789,448
7,558,897
7,489,320
10,053,810
8,995,070
8,061,790
8,635,744
9,929,615
10,303,285
9,642,531
8,117,250
8,218,852
8,112,833
8,079,332
7,832,697
4,360,537
6,489,141
8,056,996
8,251,785
8,183,848
6,235,272
6,408,248
6,899,641
6,869,775
0
0
5,582,774
5,402,188
4,736,133
5,371,110
7,239,871
4,867,085
6,644,475
5,970,070
0
05,970,0706,644,4754,867,0857,239,8715,371,1104,736,1335,402,1885,582,774006,869,7756,899,6416,408,2486,235,2728,183,8488,251,7858,056,9966,489,1414,360,5377,832,6978,079,3328,112,8338,218,8528,117,2509,642,53110,303,2859,929,6158,635,7448,061,7908,995,07010,053,8107,489,3207,558,8976,789,4485,747,3985,943,6626,293,2716,315,1525,649,5626,635,5299,044,0747,370,5757,902,7946,767,8616,281,491
       Other Current Liabilities 
5,302,760
6,976,895
3,738,421
2,645,193
3,252,984
2,789,332
4,570,227
6,455,262
6,599,402
6,788,139
6,192,063
7,703,796
4,462,992
3,846,704
5,147,078
7,712,329
8,401,985
8,382,843
9,520,931
10,666,151
9,288,239
5,389,655
5,131,182
6,968,835
4,977,113
4,672,583
5,240,036
18,579,393
14,357,859
17,403,935
15,680,012
9,244,258
15,723,023
13,256,055
10,933,633
0
0
8,665,892
13,760,027
16,010,445
700,680
507,060
537,305
486,128
433,733
0
0433,733486,128537,305507,060700,68016,010,44513,760,0278,665,8920010,933,63313,256,05515,723,0239,244,25815,680,01217,403,93514,357,85918,579,3935,240,0364,672,5834,977,1136,968,8355,131,1825,389,6559,288,23910,666,1519,520,9318,382,8438,401,9857,712,3295,147,0783,846,7044,462,9927,703,7966,192,0636,788,1396,599,4026,455,2624,570,2272,789,3323,252,9842,645,1933,738,4216,976,8955,302,760
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,278,023
17,250,779
16,495,933
16,399,649
16,101,586
16,446,603
16,191,961
16,191,96116,446,60316,101,58616,399,64916,495,93317,250,77917,278,023000000000000000000000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
35,615,130
11,812,641
11,745,542
14,222,649
25,140,951
27,916,326
18,254,694
18,506,928
19,240,408
10,251,399
11,299,218
9,553,838
7,398,632
6,782,952
6,582,925
5,195,410
4,807,675
0
0
0
0004,807,6755,195,4106,582,9256,782,9527,398,6329,553,83811,299,21810,251,39919,240,40818,506,92818,254,69427,916,32625,140,95114,222,64911,745,54211,812,64135,615,13000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-77,153,581
-3,794,283
-3,482,863
-2,842,863
-2,759,530
-2,822,030
-3,038,330
-2,888,320
-2,890,100
-46,067,561
-37,053,505
-35,866,076
-35,152,064
-33,594,555
-32,053,498
-30,566,894
-30,318,950
-27,858,647
-25,885,663
-24,784,562
-26,643,496
-30,152,227
-24,830,360
-22,378,288
-24,432,729
-25,498,035
4,198,212
4,232,590
0
04,232,5904,198,212-25,498,035-24,432,729-22,378,288-24,830,360-30,152,227-26,643,496-24,784,562-25,885,663-27,858,647-30,318,950-30,566,894-32,053,498-33,594,555-35,152,064-35,866,076-37,053,505-46,067,561-2,890,100-2,888,320-3,038,330-2,822,030-2,759,530-2,842,863-3,482,863-3,794,283-77,153,58100000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
00-10000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,655,966
1,762,605
1,865,674
2,014,159
2,190,774
2,783,750
2,978,807
4,099,401
4,310,039
5,757,425
5,437,861
5,991,883
8,211,843
9,652,310
10,517,103
10,482,886
10,584,369
10,827,889
0
0
10,454,960
10,512,645
10,500,874
0
0
0
0
0
0
00000010,500,87410,512,64510,454,9600010,827,88910,584,36910,482,88610,517,1039,652,3108,211,8435,991,8835,437,8615,757,4254,310,0394,099,4012,978,8072,783,7502,190,7742,014,1591,865,6741,762,6051,655,96600000000000000000
> Total Stockholder Equity
65,477,869
95,107,027
92,617,063
92,190,190
92,763,215
88,117,292
88,012,799
85,441,846
90,437,722
100,695,495
95,736,020
99,139,537
104,915,744
98,844,657
96,641,163
90,894,199
87,837,912
91,547,732
83,762,006
73,982,393
75,613,730
71,743,351
90,653,393
86,871,897
85,748,286
80,039,411
75,026,799
74,738,639
73,746,300
74,593,580
75,898,633
76,315,682
81,956,504
84,263,423
85,291,316
85,012,713
97,219,711
99,775,599
99,714,665
95,963,038
94,293,107
91,977,286
89,452,243
75,444,321
75,188,312
72,949,209
72,949,20975,188,31275,444,32189,452,24391,977,28694,293,10795,963,03899,714,66599,775,59997,219,71185,012,71385,291,31684,263,42381,956,50476,315,68275,898,63374,593,58073,746,30074,738,63975,026,79980,039,41185,748,28686,871,89790,653,39371,743,35175,613,73073,982,39383,762,00691,547,73287,837,91290,894,19996,641,16398,844,657104,915,74499,139,53795,736,020100,695,49590,437,72285,441,84688,012,79988,117,29292,763,21592,190,19092,617,06395,107,02765,477,869
   Common Stock
7,120,543
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,567
8,712,566
8,737,567
8,762,567
8,787,567
8,787,567
8,787,567
8,812,567
8,812,567
9,655,261
9,655,261
9,655,261
9,655,261
9,655,261
9,655,261
9,655,261
10,374,039
10,522,963
10,522,963
10,522,963
11,337,162
11,751,502
11,811,770
12,090,510
12,090,510
12,090,510
12,090,510
12,090,510
12,090,510
12,090,510
0
0
0
00012,090,51012,090,51012,090,51012,090,51012,090,51012,090,51012,090,51011,811,77011,751,50211,337,16210,522,96310,522,96310,522,96310,374,0399,655,2619,655,2619,655,2619,655,2619,655,2619,655,2619,655,2618,812,5678,812,5678,787,5678,787,5678,787,5678,762,5678,737,5678,712,5668,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5678,712,5677,120,543
   Retained Earnings 
687,751
856,001
1,024,251
1,192,501
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,346,000
1,009,500
673,000
336,500
336,500
336,500
-566,977
-2,812,542
-3,816,388
-8,095,568
-4,213,883
-9,594,347
-13,023,734
-16,383,331
-17,018,522
-33,488,724
-35,202,536
-35,191,865
-31,150,854
-34,903,818
-41,052,120
-39,106,937
-32,356,926
-29,822,565
-29,920,916
-32,477,093
-34,188,411
-35,447,436
-37,990,760
-49,284,088
-49,568,102
0
0-49,568,102-49,284,088-37,990,760-35,447,436-34,188,411-32,477,093-29,920,916-29,822,565-32,356,926-39,106,937-41,052,120-34,903,818-31,150,854-35,191,865-35,202,536-33,488,724-17,018,522-16,383,331-13,023,734-9,594,347-4,213,883-8,095,568-3,816,388-2,812,542-566,977336,500336,500336,500673,0001,009,5001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,346,0001,192,5011,024,251856,001687,751
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
80,107,251
82,957,746
82,957,746
99,350,304
102,261,053
102,260,446
102,260,446
111,366,285
118,201,789
115,701,874
120,873,108
120,872,872
120,872,872
120,872,872
120,872,872
119,838,600
119,838,600
0
0
0
000119,838,600119,838,600120,872,872120,872,872120,872,872120,872,872120,873,108115,701,874118,201,789111,366,285102,260,446102,260,446102,261,05399,350,30482,957,74682,957,74680,107,25100000000000000000000000000
   Treasury Stock00000000000-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999000-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-4,886,999-3,595,585-3,117,639-3,117,639-3,117,639-2,737,374-148,472-6,485
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,003,396
7,378,107
11,628,013
11,523,079
9,754,003
8,697,922
9,045,549
4,040,253
3,711,842
1,025,275
2,371,563
2,014,415
2,220,562
2,179,754
2,586,739
4,186,550
326,396
252,746
1,025,076
1,032,089
497,384
534,799
-660,651
1,091,286
1,097,349
1,115,630
0
0
0
0001,115,6301,097,3491,091,286-660,651534,799497,3841,032,0891,025,076252,746326,3964,186,5502,586,7392,179,7542,220,5622,014,4152,371,5631,025,2753,711,8424,040,2539,045,5498,697,9229,754,00311,523,07911,628,0137,378,10710,003,39600000000000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue137,878,037
Cost of Revenue-94,811,558
Gross Profit43,066,47943,066,479
 
Operating Income (+$)
Gross Profit43,066,479
Operating Expense-142,456,168
Operating Income-4,578,131-99,389,688
 
Operating Expense (+$)
Research Development2,638,735
Selling General Administrative28,186,186
Selling And Marketing Expenses0
Operating Expense142,456,16830,824,921
 
Net Interest Income (+$)
Interest Income720,757
Interest Expense-3,244,429
Other Finance Cost-1
Net Interest Income-2,523,671
 
Pretax Income (+$)
Operating Income-4,578,131
Net Interest Income-2,523,671
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-15,714,727-4,578,131
EBIT - interestExpense = -3,244,429
-15,587,897
-12,343,468
Interest Expense3,244,429
Earnings Before Interest and Taxes (EBIT)0-12,470,298
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-15,714,727
Tax Provision--126,830
Net Income From Continuing Ops-15,587,897-15,587,897
Net Income-15,587,897
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,523,671
 

Technical Analysis of Ctcbio
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ctcbio. The general trend of Ctcbio is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ctcbio's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of CTCBIO Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 7,680 < 8,020 < 8,230.

The bearish price targets are: 6,070 > 6,050 > 6,000.

Tweet this
CTCBIO Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of CTCBIO Inc. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

CTCBIO Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of CTCBIO Inc. The current macd is -180.98125335.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Ctcbio price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ctcbio. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ctcbio price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
CTCBIO Inc Daily Moving Average Convergence/Divergence (MACD) ChartCTCBIO Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of CTCBIO Inc. The current adx is 19.58.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ctcbio shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
CTCBIO Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of CTCBIO Inc. The current sar is 6,216.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
CTCBIO Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of CTCBIO Inc. The current rsi is 39.36. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
CTCBIO Inc Daily Relative Strength Index (RSI) ChartCTCBIO Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of CTCBIO Inc. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ctcbio price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
CTCBIO Inc Daily Stochastic Oscillator ChartCTCBIO Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of CTCBIO Inc. The current cci is -62.3861195.

CTCBIO Inc Daily Commodity Channel Index (CCI) ChartCTCBIO Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of CTCBIO Inc. The current cmo is -22.06249995.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
CTCBIO Inc Daily Chande Momentum Oscillator (CMO) ChartCTCBIO Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of CTCBIO Inc. The current willr is -48.21428571.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Ctcbio is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
CTCBIO Inc Daily Williams %R ChartCTCBIO Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of CTCBIO Inc.

CTCBIO Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of CTCBIO Inc. The current atr is 296.13.

CTCBIO Inc Daily Average True Range (ATR) ChartCTCBIO Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of CTCBIO Inc. The current obv is 33,553,307.

CTCBIO Inc Daily On-Balance Volume (OBV) ChartCTCBIO Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of CTCBIO Inc. The current mfi is 21.82.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
CTCBIO Inc Daily Money Flow Index (MFI) ChartCTCBIO Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for CTCBIO Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-25STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-26MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-08-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-09-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-15STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-16WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-07SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-09STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-10RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-12-18STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

CTCBIO Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of CTCBIO Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5039.363
Ma 20Greater thanMa 506,772.500
Ma 50Greater thanMa 1007,334.800
Ma 100Greater thanMa 2007,312.300
OpenGreater thanClose6,610.000
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Ctcbio with someone you think should read this too:
  • Are you bullish or bearish on Ctcbio? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ctcbio? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about CTCBIO Inc

I send you an email if I find something interesting about CTCBIO Inc.


Comments

How you think about this?

Leave a comment

Stay informed about CTCBIO Inc.

Receive notifications about CTCBIO Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.